TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING DEMAND FOR BIOPHARMACEUTICALS
4.2.2 GROWING ANTIBIOTIC RESISTANCE DRIVING RESEARCH
4.3 RESTRAINTS
4.3.1 HIGH CAPITAL INVESTMENT AND INFRASTRUCTURE REQUIREMENTS
4.3.2 DOWNSTREAM PROCESSING COMPLEXITY
4.4 OPPORTUNITY
4.4.1 INCREASED OUTSOURCING TO CMOS AND CDMOS
4.4.2 EXPANSION OF CRISPR AND AI IN FERMENTATION OPTIMIZATION
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS
5.1.1 RAW MATERIAL SOURCING
5.1.2 STRAIN DEVELOPMENT AND OPTIMIZATION
5.1.3 FERMENTATION PROCESS DEVELOPMENT
5.1.4 MANUFACTURING AND SCALE-UP
5.1.5 DOWNSTREAM PROCESSING
5.1.6 QUALITY CONTROL AND COMPLIANCE
5.1.7 PACKAGING AND DISTRIBUTION
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULE MARKET
5.4 POTENTIAL CUSTOMER ANALYSIS
5.5 CURRENT MARKET TRENDS
5.6 PROFITABILITY INDEX (%)
6 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS
6.1 OVERVIEW
6.2 ANTIBIOTICS
6.2.1 PENICILLIN
6.2.2 STREPTOMYCIN
6.2.3 TETRACYCLINE
6.2.4 OTHERS
6.3 HORMONES AND GROWTH FACTORS
6.3.1 INSULIN
6.3.2 HUMAN GROWTH HORMONE (HGH)
6.3.3 ERYTHROPOIETIN (EPO)
6.4 ANTICANCER AGENTS
6.4.1 DOXORUBICIN
6.4.2 DAUNORUBICIN
6.4.3 OTHERS
6.5 IMMUNOSUPPRESSANTS
6.6 OTHERS
7 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER
7.1 OVERVIEW
7.2 PHARMACEUTICAL COMPANIES
7.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) AND CDMOS
7.4 RESEARCH ORGANIZATIONS
8 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY REGION
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 ANTIBIOTICS
8.2.2 HORMONES AND GROWTH FACTORS
8.2.3 ANTICANCER AGENTS
8.2.4 IMMUNOSUPPRESSANTS
8.2.5 OTHERS
8.3 US
8.4 CANADA
8.5 EUROPE
8.5.1 ANTIBIOTICS
8.5.2 HORMONES AND GROWTH FACTORS
8.5.3 ANTICANCER AGENTS
8.5.4 IMMUNOSUPPRESSANTS
8.5.5 OTHERS
8.6 GERMANY
8.7 FRANCE
8.8 UK
8.9 ITALY
8.10 SPAIN
8.11 RUSSIA
8.12 RUSSIA
8.13 ASIA PACIFIC
8.13.1 ANTIBIOTICS
8.13.2 HORMONES AND GROWTH FACTORS
8.13.3 ANTICANCER AGENTS
8.13.4 IMMUNOSUPPRESSANTS
8.13.5 OTHERS
8.13.6 CHINA
8.13.7 INDIA
8.13.8 JAPAN
8.13.9 SOUTH KOREA
8.13.10 MALAYSIA
8.13.11 THAILAND
8.13.12 INDONESIA
8.13.13 REST OF ASIA PACIFIC
8.14 SOUTH AMERICA
8.14.1 ANTIBIOTICS
8.14.2 HORMONES AND GROWTH FACTORS
8.14.3 ANTICANCER AGENTS
8.14.4 IMMUNOSUPPRESSANTS
8.14.5 OTHERS
8.14.6 BRAZIL
8.14.7 MEXICO
8.14.8 ARGENTINA
8.14.9 REST OF SOUTH AMERICA
8.15 MIDDLE EAST AND AFRICA
8.15.1 ANTIBIOTICS
8.15.2 HORMONES AND GROWTH FACTORS
8.15.3 ANTICANCER AGENTS
8.15.4 IMMUNOSUPPRESSANTS
8.15.5 OTHERS
8.15.6 GCC COUNTRIES
8.15.7 SOUTH AFRICA
8.15.8 REST OF MEA
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MARKET SHARE ANALYSIS, 2024
9.2.1 ANALYST COMMENTS
9.3 MAJOR PLAYERS, BY REGION
9.4 COMPETITOR DASHBOARD
9.5 TOP MANUFACTURERS PRODUCTION CAPACITY DETAILS
9.6 MANUFACTURERS PRODUCTION CAPABILITIES OVERVIEW
9.7 PUBLIC PLAYERS STOCK SUMMARY
9.8 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
9.9 KEY DEVELOPMENTS & GROWTH STRATEGIES
9.9.1 ACQUISITION
9.9.2 EXPANSION
9.9.3 PRODUCT RECALL
9.9.4 PRODUCT LAUNCH/PRODUCT APPROVAL
10 COMPANY PROFILES
10.1 TEVA PHARMACEUTICAL INDUSTRIES LTD
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL OVERVIEW
10.1.3 PRODUCTS OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 PFIZER INC.
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 KEY STRATEGIES
10.3 BIOCON
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS OFFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIES
10.4 ABBOTT
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIES
10.5 ELI LILLY AND COMPANY
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 KEY STRATEGIES
10.6 NOVARTIS AG
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL OVERVIEW
10.6.3 PRODUCTS OFFERED
10.6.4 KEY DEVELOPMENTS
10.6.5 SWOT ANALYSIS
10.6.6 KEY STRATEGIES
10.7 SANOFI
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIES
10.8 ASTELLAS PHARMA INC.
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS OFFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIES
10.9 GLENMARK PHARMACEUTICALS LIMITED
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.9.6 KEY STRATEGIES
10.10 TAJ PHARMACEUTICALS LIMITED
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIES
11 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 POTENTIAL CUSTOMER ANALYSIS
TABLE 3 PROFITABILITY INDEX (%)
TABLE 4 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 5 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY REGION, 2019–2035 (USD BILLION)
TABLE 6 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 7 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR PENICILLIN, BY REGION, 2019–2035 (USD BILLION)
TABLE 8 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR STREPTOMYCIN, BY REGION, 2019–2035 (USD BILLION)
TABLE 9 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR TETRACYCLINE, BY REGION, 2019–2035 (USD BILLION)
TABLE 10 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD BILLION)
TABLE 11 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY REGION, 2019–2035 (USD BILLION)
TABLE 12 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 13 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR INSULIN, BY REGION, 2019–2035 (USD BILLION)
TABLE 14 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HUMAN GROWTH HORMONE (HGH), BY REGION, 2019–2035 (USD BILLION)
TABLE 15 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ERYTHROPOIETIN (EPO), BY REGION, 2019–2035 (USD BILLION)
TABLE 16 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY REGION, 2019–2035 (USD BILLION)
TABLE 17 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 18 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR DOXORUBICIN, BY REGION, 2019–2035 (USD BILLION)
TABLE 19 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR DAUNORUBICIN, BY REGION, 2019–2035 (USD BILLION)
TABLE 20 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD BILLION)
TABLE 21 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR IMMUNOSUPPRESSANTS, BY REGION, 2019–2035 (USD BILLION)
TABLE 22 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD BILLION)
TABLE 23 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 24 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019–2035 (USD BILLION)
TABLE 25 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR CONTRACT RESEARCH ORGANIZATIONS (CROS) AND CDMOS, BY REGION, 2019–2035 (USD BILLION)
TABLE 26 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR RESEARCH ORGANIZATIONS, BY REGION, 2019–2035 (USD BILLION)
TABLE 27 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY REGION, 2019-2035 (USD BILLION)
TABLE 28 MAJOR PLAYERS FOR NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 29 MAJOR PLAYERS FOR NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 30 MAJOR PLAYERS FOR NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 31 MAJOR PLAYERS FOR NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 32 MAJOR PLAYERS FOR NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 33 NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY COUNTRY, 2019-2035 (USD BILLION)
TABLE 34 NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019-2035 (USD BILLION)
TABLE 35 NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 36 NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 37 NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 38 NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019-2035 (USD BILLION)
TABLE 39 US MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019-2035 (USD BILLION)
TABLE 40 US MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 41 US MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 42 US MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 43 US MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019-2035 (USD BILLION)
TABLE 44 CANADA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019-2035 (USD BILLION)
TABLE 45 CANADA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 46 CANADA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 47 CANADA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 48 CANADA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019-2035 (USD BILLION)
TABLE 49 MAJOR PLAYERS FOR EUROPE MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 50 MAJOR PLAYERS FOR EUROPE MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 51 MAJOR PLAYERS FOR EUROPE MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 52 MAJOR PLAYERS FOR EUROPE MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 53 MAJOR PLAYERS FOR EUROPE MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 54 EUROPE MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY COUNTRY, 2019-2035 (USD BILLION)
TABLE 55 EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019-2035 (USD BILLION)
TABLE 56 EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 57 EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 58 EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 59 EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019-2035 (USD BILLION)
TABLE 60 GERMANY: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019-2035 (USD BILLION)
TABLE 61 GERMANY: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 62 GERMANY: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 63 GERMANY: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 64 GERMANY: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019-2035 (USD BILLION)
TABLE 65 FRANCE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019-2035 (USD BILLION)
TABLE 66 FRANCE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 67 FRANCE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 68 FRANCE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 69 FRANCE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019-2035 (USD BILLION)
TABLE 70 UK: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019-2035 (USD BILLION)
TABLE 71 UK: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 72 UK: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 73 UK: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 74 UK: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019-2035 (USD BILLION)
TABLE 75 ITALY: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019-2035 (USD BILLION)
TABLE 76 ITALY: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 77 ITALY: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 78 ITALY: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 79 ITALY: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019-2035 (USD BILLION)
TABLE 80 SPAIN: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019-2035 (USD BILLION)
TABLE 81 SPAIN: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 82 SPAIN: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 83 SPAIN: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 84 SPAIN: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019-2035 (USD BILLION)
TABLE 85 RUSSIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019-2035 (USD BILLION)
TABLE 86 RUSSIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 87 RUSSIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 88 RUSSIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 89 RUSSIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019-2035 (USD BILLION)
TABLE 90 REST OF EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019-2035 (USD BILLION)
TABLE 91 REST OF EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 92 REST OF EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 93 REST OF EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENTS, BY TYPE, 2019-2035 (USD BILLION)
TABLE 94 REST OF EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019-2035 (USD BILLION)
TABLE 95 MAJOR PLAYERS FOR ASIA-PACIFIC MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 96 MAJOR PLAYERS FOR ASIA-PACIFIC MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 97 MAJOR PLAYERS FOR ASIA-PACIFIC MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 98 MAJOR PLAYERS FOR ASIA-PACIFIC MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 99 MAJOR PLAYERS FOR ASIA PACIFIC MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 100 ASIA PACIFIC MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY REGION, 2019–2035 (USD BILLION)
TABLE 101 ASIA PACIFIC: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 102 ASIA PACIFIC: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 103 ASIA PACIFIC: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 104 ASIA PACIFIC: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 105 ASIA PACIFIC: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 106 CHINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 107 CHINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 108 CHINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 109 CHINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 110 CHINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 111 INDIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 112 INDIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 113 CHINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 114 CHINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 115 INDIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 116 JAPAN: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 117 JAPAN: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 118 JAPAN: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 119 JAPAN: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 120 JAPAN: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 121 SOUTH KOREA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 122 SOUTH KOREA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 123 SOUTH KOREA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 124 SOUTH KOREA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 125 SOUTH KOREA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 126 MALAYSIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 127 MALAYSIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 128 MALAYSIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 129 MALAYSIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 130 MALAYSIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 131 THAILAND: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 132 THAILAND: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 133 THAILAND: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 134 THAILAND: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 135 THAILAND: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 136 INDONESIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 137 INDONESIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 138 INDONESIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 139 INDONESIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 140 INDONESIA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 141 REST OF ASIA PACIFIC: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 142 REST OF ASIA PACIFIC: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 143 REST OF ASIA PACIFIC: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 144 REST OF ASIA PACIFIC: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 145 REST OF ASIA PACIFIC: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 146 MAJOR PLAYERS FOR SOUTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 147 MAJOR PLAYERS FOR SOUTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 148 MAJOR PLAYERS FOR SOUTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 149 MAJOR PLAYERS FOR SOUTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 150 MAJOR PLAYERS FOR SOUTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 151 SOUTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY REGION, 2019–2035 (USD BILLION)
TABLE 152 SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 153 SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 154 SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 155 SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 156 SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 157 BRAZIL: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 158 BRAZIL: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 159 BRAZIL: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 160 BRAZIL: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 161 BRAZIL: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 162 MEXICO: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 163 MEXICO: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 164 MEXICO: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 165 MEXICO: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 166 MEXICO: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 167 ARGENTINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 168 ARGENTINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 169 ARGENTINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 170 ARGENTINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 171 ARGENTINA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 172 REST OF SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 173 REST OF SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 174 REST OF SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 175 REST OF SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 176 REST OF SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 177 MAJOR PLAYERS FOR MIDDLE EAST AND AFRICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 178 MAJOR PLAYERS FOR MIDDLE EAST AND AFRICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 179 MAJOR PLAYERS FOR MIDDLE EAST AND AFRICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 180 MAJOR PLAYERS FOR MIDDLE EAST AND AFRICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 181 MAJOR PLAYERS FOR MIDDLE EAST AND AFRICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
TABLE 182 MIDDLE EAST AND AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY COUNTRY, 2019–2035 (USD BILLION)
TABLE 183 MIDDLE EAST AND AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 184 MIDDLE EAST AND AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 185 MIDDLE EAST AND AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 186 MIDDLE EAST AND AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 187 MIDDLE EAST AND AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 188 GCC COUNTRIES: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 189 GCC COUNTRIES: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 190 GCC COUNTRIES: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 191 GCC COUNTRIES: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 192 GCC COUNTRIES: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 193 SOUTH AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 194 SOUTH AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 195 SOUTH AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 196 SOUTH AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 197 SOUTH AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 198 REST OF MEA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2019–2035 (USD BILLION)
TABLE 199 REST OF MEA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 200 REST OF MEA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR HORMONES AND GROWTH FACTORS, BY TYPE, 2019–2035 (USD BILLION)
TABLE 201 REST OF MEA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, FOR ANTICANCER AGENT, BY TYPE, 2019–2035 (USD BILLION)
TABLE 202 REST OF MEA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2019–2035 (USD BILLION)
TABLE 203 MAJOR PLAYERS, BY REGION
TABLE 204 TOP MANUFACTURERS PRODUCTION CAPACITY DETAILS
TABLE 205 MANUFACTURERS PRODUCTION CAPABILITIES OVERVIEW
TABLE 206 PUBLIC PLAYERS STOCK SUMMARY
TABLE 207 ACQUISITION
TABLE 208 EXPANSION
TABLE 209 PRODUCT RECALL
TABLE 210 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 211 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCT OFFERED
TABLE 212 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS
TABLE 213 PFIZER INC.: PRODUCTS OFFERED
TABLE 214 BIOCON: PRODUCTS OFFERED
TABLE 215 BIOCON: KEY DEVELOPMENTS
TABLE 216 ABBOTT: PRODUCTS OFFERED
TABLE 217 ELI LILLY AND COMPANY: PRODUCTS OFFERED
TABLE 218 NOVARTIS AG: PRODUCTS OFFERED
TABLE 219 NOVARTIS AG: KEY DEVELOPMENTS
TABLE 220 SANOFI: PRODUCTS OFFERED
TABLE 221 ASTELLAS PHARMA INC: PRODUCTS OFFERED
TABLE 222 ASTELLAS PHARMA INC: KEY DEVELOPMENTS
TABLE 223 GLENMARK PHARMACEUTICALS LIMITED: PRODUCTS OFFERED
TABLE 224 TAJ PHARMACEUTICALS LTD: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET: STRUCTURE
FIGURE 2 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULE MARKET: MARKET GROWTH FACTOR ANALYSIS (2019-2035)
FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2035)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2035)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULE MARKET
FIGURE 6 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, CLASS SEGMENT ATTRACTIVENESS, 2019-2035 (USD BILLION)
FIGURE 7 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY CLASS, 2024 & 2035 (USD BILLION)
FIGURE 8 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET SHARE (%), BY CLASS, 2024
FIGURE 9 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, END USER SEGMENT ATTRACTIVENESS, 2019-2035 (USD BILLION)
FIGURE 10 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY END USER, 2024 & 2035 (USD BILLION)
FIGURE 11 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET SHARE (%), BY END USER, 2024
FIGURE 12 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY REGION, 2024 & 2035 (USD BILLION)
FIGURE 13 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET SHARE (%), BY REGION, 2024
FIGURE 14 NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2024 & 2035
FIGURE 15 NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2024 & 2035
FIGURE 16 NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2024 & 2035
FIGURE 17 NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2024 & 2035
FIGURE 18 NORTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 19 NORTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY COUNTRY, 2024 & 2035 (USD BILLION)
FIGURE 20 NORTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 21 EUROPE MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 22 EUROPE MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 23 EUROPE MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 24 EUROPE MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 25 EUROPE MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 26 EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, BY COUNTRY, 2024 & 2035 (USD BILLION)
FIGURE 27 EUROPE: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 28 ASIA-PACIFIC MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 29 ASIA-PACIFIC MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 30 ASIA-PACIFIC MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 31 ASIA-PACIFIC MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 32 ASIA PACIFIC MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 33 ASIA PACIFIC: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD BILLION)
FIGURE 34 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2024 (%)
FIGURE 35 SOUTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 36 SOUTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 37 SOUTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 38 SOUTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 39 SOUTH AMERICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 40 SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD BILLION)
FIGURE 41 SOUTH AMERICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET SHARE, BY COUNTRY, 2024 (%)
FIGURE 42 MIDDLE EAST AND AFRICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 43 MIDDLE EAST AND AFRICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 44 MIDDLE EAST AND AFRICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 45 MIDDLE EAST AND AFRICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 46 MIDDLE EAST AND AFRICA MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET, 2019 & 2035
FIGURE 47 MIDDLE EAST AND AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD BILLION)
FIGURE 48 MIDDLE EAST AND AFRICA: MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET SHARE, BY COUNTRY, 2024 (%)
FIGURE 49 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024
FIGURE 50 COMPETITOR DASHBOARD: GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SMALL MOLECULES MARKET
FIGURE 51 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 52 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
FIGURE 53 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 54 PFIZER INC.: SWOT ANALYSIS
FIGURE 55 BIOCON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 56 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 57 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 58 ELI LILLY AND COMPANY: SWOT ANALYSIS
FIGURE 59 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 60 NOVARTIS AG: SWOT ANALYSIS
FIGURE 61 SANOFI: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 62 ASTELLAS PHARMA INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 63 GLENMARK PHARMACEUTICALS LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 64 GLENMARK PHARMACEUTICALS LIMITED: SWOT ANALYSIS
